Home> Products> infusion method

{ "products": [ { "_id": "6662d50f8ecffe165c355141", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "capecitabine 500mg", "description": "CAPECITIME 500 \nCapecitabine lp 500mg\nCAPECITIME 500 represents a significant advancement in the landscape of oncological therapeutics. Manufactured with stringent quality standards by Steris Healthcare, this pharmaceutical product contains Capecitabine IP 500mg, a potent antimetabolite chemotherapy agent. It is designed to offer a balance of high efficacy and patient convenience, shifting the paradigm of cancer care from exclusively hospital-based intravenous treatments to a manageable, home-based oral regimen.\n\nIn the complex battle against malignancy, precision and tolerability are paramount. CAPECITABINE 500 serves as a 'prodrug'—a medication that remains largely inactive until it enters the body. Once ingested, it undergoes a unique three-step enzymatic conversion process, transforming into its active cytotoxic form, 5-fluorouracil (5-FU), preferentially within tumor tissues. This mechanism aims to maximize the destruction of cancer cells while striving to spare healthy tissues, making CAPECITABINE 500 a cornerstone therapy for patients battling colorectal, breast, and gastric cancers.\n\nMechanism of Action: The Science of CAPECITABINE 500\nUnderstanding how CAPECITIME 500 works is essential to appreciating its value. Unlike traditional chemotherapy that attacks all rapidly dividing cells indiscriminately, capecitabine is designed to be smarter.\n\nAbsorption and Conversion: Upon swallowing the CAPECITIME 500 tablet, the drug is absorbed through the intestinal wall. It passes through the liver, where it is converted into an intermediate compound.\n\nTumor Targeting: The final conversion to the active cancer-killing agent, 5-FU, occurs primarily in the presence of an enzyme called thymidine phosphorylase. Research indicates that this enzyme is often found in higher concentrations in tumor tissues compared to normal healthy tissues.\n\nDNA Disruption: Once active inside the cancer cell, the drug mimics essential nutrients the cell needs to grow (specifically inhibiting thymidylate synthase). This effectively 'starves' the cancer cell of the building blocks required for DNA replication and repair, leading to cell death (apoptosis) and slowing tumor progression.\n\nTherapeutic Indications and Uses\nCAPECITABINE 500 is a versatile oncology medication prescribed by specialists for several specific types of cancer. Its efficacy is well-documented in various clinical settings:\n\n1. Colorectal Cancer\nAdjuvant Treatment: CAPECITIME 500 is widely used for patients with Stage III (Dukes' C) colon cancer who have undergone surgery to remove the primary tumor. In this setting, the drug acts as a 'cleanup' agent, targeting any microscopic cancer cells that may remain, significantly reducing the risk of recurrence and improving survival rates.\n\nMetastatic Colorectal Cancer: For cases where the cancer has spread (metastasized) to other parts of the body, CAPECITIME 500 is often the first-line treatment. It can be used as a standalone therapy (monotherapy) or in combination with other chemotherapy agents to control disease progression.\n\n2. Breast Cancer\nAdvanced or Metastatic Disease: CAPECITIME 500 plays a critical role in treating advanced breast cancer. It is frequently prescribed when the cancer has stopped responding to other standard chemotherapy treatments, such as paclitaxel or anthracyclines.\n\nCombination Therapy: It is often paired with other drugs (e.g., docetaxel) to enhance the attack on cancer cells, providing a synergistic effect that can shrink tumors more effectively than single agents alone.\n\n3. Gastric (Stomach) Cancer\nCAPECITABINE 500 is also a key component in the treatment regimen for advanced gastric cancer, often used in combination with platinum-based chemotherapy. It helps in palliative care settings to extend survival and improve the quality of life for patients with inoperable tumors.\n\nKey Benefits of CAPECITIME 500\nPatients and healthcare providers choose CAPECITABINE 500 for several distinct advantages that set it apart from conventional intravenous chemotherapy.\n\n1. Convenience of Oral Administration\nPerhaps the most immediate benefit for the patient is the form factor. Traditional 5-FU treatment requires continuous intravenous (IV) infusion, necessitating frequent hospital visits, catheter lines, or portable pumps. CAPECITIME 500 is a tablet. This allows patients to take their medication in the comfort of their own homes, reducing hospital visits and allowing them to maintain a more normal daily routine, work schedule, and family life.\n\n2. Targeted 'Tumor-Activated' Therapy\nBecause the drug is converted to its active form largely within the tumor site (due to higher enzyme levels there), CAPECITIME 500 achieves high concentrations of medicine exactly where it is needed—inside the cancer. This targeted approach aims to reduce systemic toxicity compared to older chemotherapy methods that flood the entire bloodstream with active toxins.\n\n3. Proven Efficacy & Quality\nManufactured by Steris Healthcare, CAPECITIME 500 adheres to WHO-GMP (Good Manufacturing Practices) standards, ensuring that patients receive a product of high purity, stability, and consistent dosage. Clinical data supports that oral Capecitabine is at least equivalent to intravenous 5-FU in terms of survival outcomes for colorectal cancer, with the added benefit of improved convenience.\n\n4. Flexible Combination Partner\nCAPECITIME 500 is highly versatile. It can be effectively combined with a wide range of other cancer therapies, including radiation therapy and biologic agents, allowing oncologists to tailor treatment plans to the specific genetic makeup and stage of the patient's cancer.\n\nPotential Side Effects and Management\nWhile CAPECITIME 500 is designed to be more targeted, it is still a potent chemotherapy drug, and side effects can occur. Being aware of these helps patients manage them effectively.\n\nCommon Side Effects\nGastrointestinal Issues: Diarrhea, nausea, vomiting, and abdominal pain are common. These are usually manageable with dietary changes and additional medications prescribed by the doctor.\n\nFatigue: A general sense of tiredness or weakness is frequently reported.\n\nHand-Foot Syndrome (Palmar-Plantar Erythrodysesthesia): This is a specific side effect where the palms of the hands and soles of the feet become red, swollen, tender, or peeled. It is caused by small amounts of the drug leaking from capillaries in these areas.\n\nSerious Side Effects (Rare but Important)\nCardiac Symptoms: Rarely, patients may experience chest pain or heart palpitations.\n\nLow Blood Cell Counts: The drug can temporarily lower the number of white blood cells (increasing infection risk), red blood cells (anemia), and platelets (bruising).\n\nSevere Diarrhea: If left untreated, this can lead to dehydration.\n\nManaging Side Effects\nHydration: Patients are advised to drink plenty of fluids.\n\nSkin Care: For Hand-Foot Syndrome, keeping hands and feet moisturized, avoiding tight shoes, and staying away from hot water/heat sources is recommended.\n\nCommunication: Early reporting of side effects to a healthcare provider often allows for dose adjustments that can stop the side effects from becoming severe.\n\nDosage and Administration\nPrescription Only: CAPECITABINE 500 is a prescription-only medicine and must be taken exactly as directed by an oncologist.\n\nTypical Cycle: A common regimen involves taking the tablets twice daily (morning and evening) for 14 consecutive days, followed by a 7-day rest period. This constitutes one 21-day cycle.\n\nWith Food: It is crucial to take CAPECITIME 500 within 30 minutes after a meal with water. Taking it with food reduces the risk of stomach upset and ensures proper absorption.\n\nConclusion\nCAPECITIME 500 (Capecitabine 500mg) stands as a vital therapeutic option in modern oncology. By combining the potency of traditional chemotherapy with the smart science of tumor-enzyme activation, it offers a powerful weapon against colorectal, breast, and gastric cancers.\n\nBeyond its chemical efficacy, CAPECITIME 500 offers the profound benefit of dignity and independence. The ability to self-administer chemotherapy at home empowers patients, reducing the burden of clinical visits and allowing them to focus more on healing and living. With its high-quality formulation by Steris Healthcare, CAPECITIME 500 provides a reliable, effective, and patient-centric solution for cancer management.", "price": 1222.0, "discountamount": 366.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "body", "Call", "blood", "Email", "class", "amount", "nausea", "doctor", "disorder", "WhatsApp", "headache", "CABERGLOW", "dizziness", "conditions", "CAPECITIME", "medication", "infertility", "information", "Capecitabine", "constipation", "instructions", "sterispharma", "sterisonline", "Cabergoline IP", "unusual symptoms", "hyperprolactinemia", "associated symptoms", "Excessive prolactin", "Common side effects", "other related issues", "normal hormone levels", "healthcare professional", "excess prolactin hormone", "dopamine receptor agonists", "irregular menstrual periods" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1525, "imageuri": "https://productimages.withfloats.com/actual/667d2be5cd6f42ac046088e1.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2be5cd6f42ac046088e1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T09:38:23.283Z", "updatedon": "2026-03-17T07:22:43.148Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/capecitabine-500mg/1525", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CAPECITIME 500 ", "category": "NEPHROLOGYRANGE", "tags": [ "capecitabine 500 mg tablet price", "capecitabine 500 mg tablet dosage", "capecitabine 500 mg tablet side effects", "CAPECITIME 500", "Capecitabine IP 500mg", "Combination Therapy", "CAPECITIME 500 is a tablet.", "colorectal, breast, and gastric cancers.", "CAPECITIME 500", "5-FU in terms of survival outcomes for colorectal cancer.", "capecitabine 500mg oral chemotherapy tablets", "capecitabine 500mg chemotherapy at home", "capecitabine 500mg for metastatic breast cancer", "buy capecitabine 500mg online", "capecitabine 500mg price per tablet" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a8c3838c90065ecdc86c757", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 4mg", "description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.", "price": 6600.0, "discountamount": 1980.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2497, "imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:25:28.659Z", "updatedon": "2026-08-24T12:25:28.659Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-4mg/2497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 4 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a8c35e76d1f6b0cbc0e2e40", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 2 mg", "description": "SAMIGLUTIDE 2 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation is Semaglutide Injection 2 mg/3 mL (0.68 mg/mL). Semaglutide belongs to the GLP-1 receptor agonist class and is a prescription medicine that should be used only under the supervision of an appropriately qualified healthcare professional.\n\nSAMIGLUTIDE 2 MG Composition\n\nEach 3 mL pre-filled pen is stated to contain:\n\nActive substance: Semaglutide\nStrength: 2 mg/3 mL\nConcentration: 0.68 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute of administration: Subcutaneous, according to the applicable product instructions\n\nSemaglutide acts on GLP-1 receptors, which are involved in blood-glucose regulation and appetite control. The approved uses, dosage regimen and strength available can differ according to the specific product and the regulations of the country in which it is supplied.\n\nWhat Is Semaglutide?\n\nSemaglutide is a synthetic peptide that mimics the activity of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). By activating GLP-1 receptors, it can influence several physiological processes, including glucose-dependent insulin release, glucagon secretion, gastric emptying and appetite.\n\nThe appropriate dose and treatment schedule depend on the individual patient and the particular semaglutide formulation. Patients should follow their healthcare professional's instructions and should not alter the prescribed regimen independently.\n\nSAMIGLUTIDE 2 MG Pre-Filled Pen\n\nSAMIGLUTIDE 2 MG is presented as a pre-filled injection pen intended to provide a convenient method of administration when the medicine has been prescribed.\n\nSince semaglutide products can differ in concentration, pen design and dose-delivery mechanism, users should carefully verify the product label and prescribed dose before each administration. Particular care is important with injectable semaglutide products because differences in concentration or measurement methods can result in medication errors.\n\nPotential Medical Uses\n\nSemaglutide may be used for particular medical conditions depending on the formulation, regulatory approval and prescribing information applicable to the product.\n\nCertain approved semaglutide medicines are indicated for the treatment of type 2 diabetes, while other formulations have approved indications involving chronic weight management in eligible patients. Some products may also have additional approved indications for reducing specific cardiovascular risks.\n\nThe fact that semaglutide can be used for weight management does not mean that every semaglutide product is approved for that purpose. The authorization and labeling of SAMIGLUTIDE should therefore be confirmed from current official product documentation.\n\nHow Semaglutide Works\n\nSemaglutide activates GLP-1 receptors in the body. Its effects can contribute to improved regulation of blood glucose and reduced appetite and food intake. Depending on the approved indication, it may be prescribed together with dietary, physical-activity or other appropriate medical measures.\n\nIndividual responses can vary. Medical follow-up helps healthcare professionals evaluate treatment response, tolerability and whether treatment should be continued or modified.\n\nDosage and Administration\n\nSAMIGLUTIDE 2 MG should be administered only in accordance with the prescription and the manufacturer's current instructions.\n\nThe amount of semaglutide contained in a pen should not automatically be interpreted as the amount to inject at one time. Different products may use different concentrations, dose settings and administration schedules.\n\nFor approved semaglutide products, treatment may involve gradual dose increases for certain indications. Patients should never increase the dose, inject more frequently or repeat a missed dose without receiving appropriate medical instructions.\n\nPossible Side Effects\n\nSemaglutide can cause adverse effects, particularly gastrointestinal symptoms. Frequently reported effects may include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nAbdominal pain\n\nMore serious reactions are also possible. Product information for semaglutide medicines includes warnings relating to conditions such as pancreatitis and gallbladder disorders, among other potential risks.\n\nPersistent, severe or unusual symptoms should be discussed promptly with a healthcare professional. Patients should review the complete prescribing information supplied with their particular product.\n\nImportant Safety Information\n\nSemaglutide is not appropriate for everyone. For example, certain approved semaglutide products in the United States carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and individuals with a serious hypersensitivity to semaglutide or an ingredient in the relevant product.\n\nThese precautions should not automatically be assumed to apply identically to every semaglutide product worldwide. The manufacturer's labeling and the regulatory requirements of the relevant country should always be consulted.\n\nPatients should inform their healthcare professional about their medical history and other medicines before starting treatment.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can make injectable treatment more convenient by providing the medication in a ready-to-use delivery device. When used according to the manufacturer's instructions, the pen may simplify administration and help patients maintain their prescribed treatment routine.\n\nPatients should nevertheless receive appropriate guidance regarding injection technique, storage, handling and disposal. The convenience of a pen does not eliminate the need for medical supervision.\n\nStorage and Handling\n\nSAMIGLUTIDE 2 MG should be stored exactly as stated on its packaging and official product information. Appropriate storage conditions are important for maintaining the quality and stability of the medicine.\n\nBefore use, check the expiry date and inspect the packaging and medicine according to the manufacturer's instructions. Do not use the product if the packaging is damaged or if the solution has an appearance that does not meet the stated product requirements.\n\nConclusion\n\nSAMIGLUTIDE 2 MG – Semaglutide Injection 2 mg/3 mL (0.68 mg/mL) is a semaglutide-based injectable formulation supplied in a pre-filled pen. Semaglutide is a GLP-1 receptor agonist with established medical applications for appropriately selected patients, depending on the specific product and its regulatory authorization.\n\nSafe use requires adherence to the prescribed dose and administration schedule. Patients should not independently change their dose or frequency and should seek professional advice if they experience concerning adverse effects.\n\nBecause formulations, indications, strengths and regulatory requirements can vary between products and countries, the current official package insert and applicable regulatory labeling should be used to verify product-specific information.\n\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 2 MG?\n\nSAMIGLUTIDE 2 MG is described as a semaglutide injection containing 2 mg of semaglutide in 3 mL, with a stated concentration of 0.68 mg/mL, supplied in a pre-filled pen.\n\nIs SAMIGLUTIDE 2 MG used for weight management?\n\nSemaglutide is included in certain approved medicines used for chronic weight management in eligible patients. However, the indication for a specific SAMIGLUTIDE product must be confirmed from its current regulatory approval and official labeling.\n\nHow frequently is SAMIGLUTIDE 2 MG injected?\n\nThe correct frequency depends on the specific product and the prescription issued by the healthcare professional. Patients should not determine the injection schedule based solely on the amount printed on the pen.\n\nCan SAMIGLUTIDE 2 MG be taken without medical supervision?\n\nNo. Semaglutide is a prescription medicine in many jurisdictions and should be obtained and used through legitimate, appropriately regulated healthcare channels.\n\nIs SAMIGLUTIDE the same as other branded semaglutide medicines?\n\nNot necessarily. Products containing semaglutide can differ in manufacturer, formulation, concentration, delivery device, regulatory approval and approved indications. A specific product should not be described as identical to an approved branded medicine unless that claim can be verified through reliable regulatory and product documentation.\n\nWhat should patients check before using the pen?\n\nPatients should verify the medicine name, strength, prescribed dose, expiry date, storage conditions and administration instructions. If there is any uncertainty about the dose or operation of the pen, they should consult their pharmacist, prescriber or another qualified healthcare professional rather than guessing.", "price": 5600.0, "discountamount": 1680.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2496, "imageuri": "https://productimages.withfloats.com/actual/6a8c35eaca4d2575d78e3716.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c35eaca4d2575d78e3716.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:15:35.873Z", "updatedon": "2026-08-24T12:15:35.873Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-2-mg/2496", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 2 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a460bf90c11f3c74a816c87", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "methylprednisolone sodium succinate for injection usp", "description": "Methylprednisolone Sodium Succinate for Injection USP is a fast-acting corticosteroid administered intravenously or intramuscularly to control severe inflammation, allergic reactions, and autoimmune flare-ups. It works by rapidly suppressing the immune and inflammatory response and is used in hospital or clinical settings for acute conditions such as severe asthma attacks, anaphylaxis, autoimmune disease flares, and spinal cord injury protocols. It is a Schedule H prescription drug administered only under medical supervision.\n\nWhat Is Methylprednisolone Sodium Succinate for Injection USP?\n\nMethylprednisolone Sodium Succinate for Injection USP is a water-soluble, injectable corticosteroid used for rapid control of severe inflammatory, allergic, and autoimmune conditions. It is manufactured to United States Pharmacopeia (USP) standards and is typically administered by a healthcare professional via intravenous (IV) or intramuscular (IM) route when fast, high-potency anti-inflammatory or immunosuppressive action is required — situations where oral steroids act too slowly or oral intake isn't feasible.\n\nHow It Works\n\nMethylprednisolone sodium succinate is a synthetic glucocorticoid that acts rapidly once reconstituted and injected.\n\n\nBinds glucocorticoid receptors – enters cells and binds intracellular receptors that regulate inflammatory gene expression.\nSuppresses inflammatory mediators – reduces production of prostaglandins, leukotrienes, and cytokines responsible for swelling, redness, and pain.\nStabilizes cell membranes – reduces capillary permeability, limiting fluid leakage and tissue swelling at the site of inflammation.\nDampens immune overactivity – suppresses lymphocyte and macrophage activity, calming autoimmune or allergic overreactions.\nDelivers rapid systemic action – because it's water-soluble and given IV/IM, onset of anti-inflammatory effect is significantly faster than oral steroids.\n\n\nClinical Indications\n\nConditionWhy Methylprednisolone Injection Is UsedSevere Allergic Reactions / AnaphylaxisRapidly controls swelling, airway inflammation, and allergic cascadeAcute Asthma Exacerbation / COPD FlareReduces airway inflammation when inhalers alone are insufficientAutoimmune Disease Flares (Lupus, Rheumatoid Arthritis)High-dose pulse therapy to control acute flaresSpinal Cord Injury (acute, under specialist protocol)Used in specific clinical protocols to limit secondary inflammationSevere Dermatologic ReactionsControls widespread inflammatory skin reactionsPost-Transplant / Organ Rejection ManagementUsed as part of immunosuppressive regimens\n\nDosage & Administration\n\nParameterRecommendationTypical Adult Dose10–40 mg IV, may range up to 30 mg/kg in high-dose pulse therapy for specific conditionsRouteIntravenous (IV) injection/infusion or Intramuscular (IM) injectionFrequencyAs directed by the treating physician; often single dose or short tapering courseReconstitutionMust be reconstituted only with the accompanying diluent as per product insert, immediately before useAdministration SettingHospital, clinic, or under direct medical/nursing supervision onlyDurationShort-term acute use unless otherwise directed; long-term use requires specialist monitoring\n\nThis is a Schedule H prescription-only medicine. Dosage must be determined and administered by a qualified healthcare professional.\n\nPrecautions\n\n\nTo be administered only by or under the supervision of a healthcare professional.\nNot for self-administration or home use.\nInform the doctor of any active infections, as corticosteroids can mask symptoms and suppress immune response.\nUse with caution in patients with diabetes, hypertension, peptic ulcer disease, osteoporosis, or psychiatric history.\nAvoid live vaccines during treatment due to immunosuppressive effects.\nPregnant or breastfeeding patients should use only under strict medical guidance.\nAbrupt discontinuation after prolonged use should be avoided; tapering may be required as advised by the physician.\n\n\nPossible Side Effects\n\nMost side effects relate to the drug's systemic corticosteroid action and are monitored by the administering clinician:\n\n\nElevated blood sugar levels\nFluid retention, increased blood pressure\nMood changes, insomnia, or restlessness\nNausea or gastrointestinal discomfort\nIncreased susceptibility to infection\nInjection site reactions\n\n\nSerious side effects requiring immediate medical attention include severe allergic reaction, signs of infection (fever, chills), significant mood or behavioral changes, unusual swelling, or vision disturbances. Because this is administered in a clinical setting, the healthcare team monitors for these actively.\n\nComparison: Methylprednisolone vs. Other Injectable Corticosteroids\n\nDrugRelative PotencyCommon Use CaseRouteMethylprednisolone Sodium SuccinateHighAcute severe inflammation, autoimmune flaresIV/IMHydrocortisone Sodium SuccinateLowerAdrenal insufficiency, milder acute inflammationIV/IMDexamethasone Sodium PhosphateVery HighCerebral edema, severe allergic/inflammatory conditionsIV/IMBetamethasone Sodium PhosphateHighAllergic and inflammatory conditions, fetal lung maturityIV/IMTriamcinolone AcetonideModerate (depot)Localized/intra-articular inflammationIM/Intra-articular\n\nKey Statistics\n\nStatisticData PointSourceOnset of anti-inflammatory action after IV administrationWithin 1–2 hours for measurable effectClinical pharmacology references, USP monographUse in acute severe asthma protocolsRecommended as part of systemic corticosteroid therapy in emergency guidelinesGlobal Initiative for Asthma (GINA) guidelinesHospital use in anaphylaxis managementIncluded as an adjunct in anaphylaxis treatment protocols alongside epinephrineWorld Allergy Organization guidanceHigh-dose pulse therapy applicationUsed in select autoimmune flare protocols under specialist supervisionPublished rheumatology treatment guidelines\n\nExpert Insight\n\n[Insert verified physician or clinical pharmacologist commentary here — Claude has not fabricated a quote. Recommend sourcing a short, attributable statement from a Steris Healthcare medical advisor or a cited clinical guideline before publishing.]\n\nConclusion\n\nMethylprednisolone Sodium Succinate for Injection USP is a high-potency, fast-acting corticosteroid reserved for situations where rapid control of severe inflammation, allergic reaction, or autoimmune flare is essential. Administered only under clinical supervision, it plays a critical role in emergency and hospital-based treatment protocols — from anaphylaxis and acute asthma to autoimmune disease management. As a Schedule H medicine, it must never be self-administered; dosage, route, and duration should always be determined by a qualified physician based on the patient's condition. For pharmacopoeia-grade quality and reliable hospital supply, source this injection through a WHO-GMP certified manufacturer.\n\nPrescription only – consult your doctor.\n\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\n\n1. What is methylprednisolone sodium succinate injection used for?\nIt is used to rapidly control severe inflammation, allergic reactions, and autoimmune flare-ups, such as anaphylaxis, acute asthma attacks, and lupus or rheumatoid arthritis flares. It is administered under medical supervision in hospital or clinical settings.\n\n2. Is methylprednisolone injection a steroid?\nYes, it is a synthetic corticosteroid (glucocorticoid) that works by suppressing inflammatory and immune responses in the body, providing rapid relief in acute, severe conditions.\n\n3. How is methylprednisolone sodium succinate injection given?\nIt is given by a healthcare professional via intravenous (IV) or intramuscular (IM) injection, after being reconstituted with the correct diluent immediately before administration. It is not for self-injection or home use.\n\n4. How fast does methylprednisolone injection start working?\nBecause it is water-soluble and given directly into the bloodstream or muscle, measurable anti-inflammatory effects typically begin within one to two hours of administration.\n\n5. What are the side effects of methylprednisolone injection?\nCommon effects include elevated blood sugar, fluid retention, mood changes, and increased infection risk. These are monitored by the administering healthcare team, and serious reactions are managed promptly in a clinical setting.\n\n6. Is methylprednisolone sodium succinate injection available without a prescription?\nNo. It is a Schedule H prescription-only medicine that must be administered by or under the direct supervision of a qualified healthcare professional.\n\n7. What is the difference between methylprednisolone and dexamethasone injection?\nBoth are injectable corticosteroids, but dexamethasone has a longer duration of action and higher relative potency, while methylprednisolone is often preferred for acute pulse therapy and shorter-acting systemic control. The choice depends on the clinical scenario and physician judgment.\n\n8. Can methylprednisolone injection be used in pregnancy?\nIt may be used in pregnancy only when clearly necessary and under strict medical supervision, as the treating physician will weigh the benefits against potential risks for the specific condition being treated.", "price": 47.0, "discountamount": 19.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2465, "imageuri": "https://productimages.withfloats.com/actual/6a460bfb9f5529389b8b15b8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a460bfb9f5529389b8b15b8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-02T06:58:01.631Z", "updatedon": "2026-07-02T06:58:01.631Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//methylprednisolone-sodium-succinate-for-injection-usp/2465", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METHIDENOSOLE 40 INJ", "category": "GENERAL RANGE", "tags": [ "methylprednisolone sodium succinate injection uses", "methylprednisolone sodium succinate injection uses in hindi", "methylprednisolone sodium succinate", "methylprednisolone sodium succinate injection", "inj methylprednisolone sodium succinate", "methylprednisolone sodium succinate uses in hindi", "methylprednisolone sodium succinate for injection", "methylprednisolone sodium succinate injection usp" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a323d7d8e48e7ba2094cc7f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "nimodipine 60 mg", "description": "When looking for an effective medication for specific neurological and blood vessel-related conditions, Nimodipine 60 mg is a widely prescribed treatment known for its role in improving blood flow to the brain. Healthcare professionals commonly recommend this medicine for patients requiring specialized management of cerebral blood vessel complications.\n\nIf you are researching Nimodipine 60 mg, understanding its uses, benefits, dosage, safety profile, and purchasing considerations can help you make an informed decision. This comprehensive guide covers everything you need to know before buying or using Nimodipine 60 mg.\n\nWhat Is Nimodipine 60 mg?\n\nNimodipine 60 mg is a prescription medication that belongs to a class of drugs called calcium channel blockers. Unlike many calcium channel blockers that primarily affect the heart and peripheral blood vessels, nimodipine is specially designed to target blood vessels in the brain.\n\nIt is most commonly used to reduce the risk of brain damage caused by decreased blood flow following certain neurological events. By relaxing and widening cerebral blood vessels, nimodipine helps maintain adequate oxygen and nutrient delivery to brain tissue.\n\nBecause of its specialized action, Nimodipine 60 mg should only be used under medical supervision and according to prescribed treatment guidelines.\n\nComposition of Nimodipine 60 mg\n\nEach tablet contains:\n\nIngredient\tStrength\nNimodipine\t60 mg\n\nThe active ingredient works by controlling the movement of calcium into smooth muscle cells of blood vessels, helping them remain relaxed and open.\n\nHow Does Nimodipine 60 mg Work?\n\nNimodipine acts by blocking calcium channels located in the smooth muscle cells lining blood vessel walls.\n\nMechanism of Action\nCalcium normally enters vascular smooth muscle cells.\nThis calcium causes blood vessels to contract.\nNimodipine blocks calcium entry.\nBlood vessels relax and widen.\nImproved blood flow reaches brain tissues.\n\nThe unique property of nimodipine is its high affinity for cerebral arteries. This makes it particularly valuable in neurological settings where maintaining adequate cerebral circulation is critical.\n\nBy reducing blood vessel constriction, Nimodipine 60 mg helps support oxygen delivery and may lower the risk of complications associated with reduced cerebral blood flow.\n\nUses of Nimodipine 60 mg\n\nHealthcare providers may prescribe Nimodipine 60 mg for the management of conditions involving cerebral circulation.\n\nCommon Medical Uses\n1. Prevention of Cerebral Vasospasm\n\nNimodipine is widely used to prevent narrowing of brain blood vessels after certain neurological events.\n\n2. Support of Brain Blood Flow\n\nThe medication helps improve circulation in cerebral arteries and supports oxygen supply to brain tissues.\n\n3. Neurological Care Protocols\n\nIn specialized hospital settings, nimodipine may form part of comprehensive neurological treatment plans.\n\n4. Reduction of Ischemic Complications\n\nBy maintaining adequate blood flow, the medication may help reduce complications associated with restricted cerebral circulation.\n\nAlways follow your doctor's recommendations regarding the exact purpose and duration of treatment.\n\nKey Benefits of Nimodipine 60 mg\nImproved Cerebral Blood Flow\n\nThe primary benefit of Nimodipine 60 mg is its ability to enhance blood circulation within the brain.\n\nTargeted Action\n\nUnlike many other calcium channel blockers, nimodipine specifically affects cerebral blood vessels.\n\nNeuroprotective Support\n\nMaintaining adequate blood flow helps support brain tissue function and recovery.\n\nWell-Established Clinical Use\n\nNimodipine has been extensively studied and is commonly included in neurological treatment protocols worldwide.\n\nReliable Therapeutic Effect\n\nWhen taken as prescribed, Nimodipine 60 mg provides consistent therapeutic support for cerebral vascular health.\n\nWhy Choose Nimodipine 60 mg?\n\nMany healthcare professionals choose nimodipine because of its unique brain-selective properties.\n\nAdvantages Include:\nSpecifically targets cerebral arteries\nSupports healthy blood circulation in the brain\nProven clinical history\nPrescription-based safety monitoring\nWidely recognized neurological therapy\nSuitable for structured treatment protocols\n\nPatients searching for Nimodipine 60 mg online often prioritize quality, authenticity, and professional medical guidance when purchasing this medication.\n\nDosage and Administration\n\nThe dosage of Nimodipine 60 mg depends on individual medical needs and physician recommendations.\n\nGeneral Guidelines\nTake exactly as prescribed.\nSwallow the tablet with water.\nFollow scheduled dosing intervals.\nDo not exceed the prescribed dose.\nContinue treatment for the full duration recommended by your healthcare provider.\nImportant Instructions\nAvoid self-adjusting the dosage.\nDo not stop treatment abruptly unless advised by your doctor.\nInform your physician about all medications you are taking.\n\nBecause dosing schedules may vary, always rely on professional medical advice.\n\nPossible Side Effects of Nimodipine 60 mg\n\nLike all prescription medicines, Nimodipine 60 mg may cause side effects in some individuals.\n\nCommon Side Effects\nHeadache\nDizziness\nFlushing\nNausea\nFatigue\nLow blood pressure\nLess Common Side Effects\nRapid heartbeat\nSwelling of extremities\nGastrointestinal discomfort\nLightheadedness\nSeek Medical Attention If You Experience\nSevere allergic reactions\nSignificant drop in blood pressure\nDifficulty breathing\nSevere dizziness or fainting\n\nMost side effects are manageable and should be discussed with your healthcare provider.\n\nSafety Precautions\n\nBefore using Nimodipine 60 mg, discuss your complete medical history with your doctor.\n\nInform Your Physician If You Have:\nLiver disease\nLow blood pressure\nHeart conditions\nKidney disorders\nHistory of medication allergies\nPregnancy and Breastfeeding\n\nConsult your healthcare provider regarding the use of Nimodipine 60 mg during pregnancy or breastfeeding.\n\nDrug Interactions\n\nCertain medications may interact with nimodipine, including:\n\nBlood pressure medications\nAntifungal drugs\nAntibiotics\nAnti-seizure medications\nCertain heart medications\n\nAlways provide a complete medication list to your healthcare professional.\n\nHow to Store Nimodipine 60 mg\n\nProper storage helps maintain the medication's effectiveness.\n\nStorage Guidelines\nStore at room temperature.\nKeep away from direct sunlight.\nProtect from moisture.\nKeep out of reach of children.\nStore in original packaging whenever possible.\n\nDo not use expired medication.\n\nBuying Nimodipine 60 mg Online\n\nWhen purchasing Nimodipine 60 mg online, prioritize safety and authenticity.\n\nWhat to Look For\nLicensed pharmacy or supplier\nGenuine product sourcing\nPrescription verification\nSecure payment methods\nProper packaging\nCustomer support availability\nBuyer Checklist\n\n✔ Verify product strength (60 mg)\n\n✔ Check manufacturing details\n\n✔ Confirm prescription requirements\n\n✔ Review storage recommendations\n\n✔ Ensure sealed packaging upon delivery\n\nChoosing a reputable supplier helps ensure product quality and patient safety.\n\nConclusion\n\nNimodipine 60 mg is a specialized calcium channel blocker designed to support healthy cerebral blood flow. Its targeted action on brain blood vessels makes it an important medication in neurological care and vascular management protocols.\n\nWhether you are researching treatment options or planning to purchase Nimodipine 60 mg with a valid prescription, understanding its benefits, dosage guidelines, precautions, and potential side effects is essential. Always use this medication under the supervision of a qualified healthcare professional to achieve the best possible outcomes.\n\nHigh-Ranking FAQs (Google Search & Voice Search Optimized)\nWhat is Nimodipine 60 mg used for?\n\nNimodipine 60 mg is primarily used to improve blood flow in the brain and help prevent complications related to cerebral blood vessel narrowing under medical supervision.\n\nHow does Nimodipine 60 mg work?\n\nIt blocks calcium entry into blood vessel muscle cells, allowing cerebral arteries to relax and improving blood circulation to brain tissues.\n\nIs Nimodipine 60 mg a blood thinner?\n\nNo. Nimodipine is not a blood thinner. It is a calcium channel blocker that relaxes blood vessels.\n\nCan Nimodipine 60 mg lower blood pressure?\n\nYes. Nimodipine may lower blood pressure as part of its blood vessel-relaxing effects.\n\nHow long should I take Nimodipine 60 mg?\n\nThe duration of treatment depends on your medical condition and your doctor's recommendations.\n\nCan I take Nimodipine 60 mg with food?\n\nFollow your physician's instructions regarding food intake and dosing schedules for optimal results.\n\nWhat are the most common side effects of Nimodipine 60 mg?\n\nCommon side effects include headache, dizziness, nausea, flushing, fatigue, and low blood pressure.\n\nIs Nimodipine 60 mg available without a prescription?\n\nNo. Nimodipine 60 mg is generally a prescription-only medication and should be used under medical supervision.\n\nCan elderly patients use Nimodipine 60 mg?\n\nYes, but dosage and monitoring should be determined by a healthcare professional based on individual health conditions.\n\nWhere can I buy genuine Nimodipine 60 mg online?\n\nYou should purchase Nimodipine 60 mg only from reputable and licensed pharmacies that provide authentic prescription medications and proper product information.", "price": 240.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2455, "imageuri": "https://productimages.withfloats.com/actual/6a323d80854c6b9cdfe7c9ab.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a323d80854c6b9cdfe7c9ab.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-17T06:23:57.291Z", "updatedon": "2026-06-17T06:58:50.317Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nimodipine-60-mg/2455", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NIMONIDIP 60", "category": "CARDIOLOGYRANGE", "tags": [ "nimodipine 60 mg", "nimodipine 60 mg price", "tab nimodipine 60 mg", "nimodipine 60 mg uses in hindi", "tab nimodipine 60 mg uses", "nimodipine 60 mg brand name", "tab nimodipine 60 mg uses in hindi", "nimodipine 60 mg tablet uses", "nimodipine 60 mg tablet uses", "nimodipine 60 mg price in india" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a2937c45f38850c17a50eea", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "minoxidil topical solution usp 2%", "description": "Introduction to Minoxidil Topical Solution USP 2%\n\nMinoxidil Topical Solution USP 2% is a clinically proven hair regrowth treatment widely used for managing hair thinning and hair loss in both men and women. Originally developed as a medication for high blood pressure, researchers discovered that Minoxidil had a remarkable ability to stimulate hair growth and improve hair density. Today, it is one of the most trusted and dermatologist-recommended treatments for androgenetic alopecia (pattern baldness) and other forms of hair loss.\n\nHair loss can significantly affect self-confidence and quality of life. Whether caused by genetics, hormonal changes, stress, aging, or medical conditions, thinning hair can be frustrating. Minoxidil Topical Solution USP 2% offers a scientifically backed solution designed to revitalize hair follicles, improve scalp circulation, and promote healthier, thicker hair growth.\n\nThis comprehensive guide explains everything you need to know about Minoxidil Topical Solution USP 2%, including its uses, benefits, mechanism of action, side effects, application methods, and frequently asked questions.\n\nWhat Is Minoxidil Topical Solution USP 2%?\n\nMinoxidil Topical Solution USP 2% is an external-use medication applied directly to the scalp to promote hair regrowth and slow down progressive hair loss. It contains 2% Minoxidil as the active ingredient and is formulated specifically to stimulate hair follicles and encourage healthy hair growth.\n\nThis topical treatment is commonly prescribed or recommended for individuals experiencing:\n\nMale pattern baldness\nFemale pattern hair loss\nHair thinning\nEarly-stage alopecia\nReduced hair density\n\nThe 2% strength is often preferred for women and individuals seeking a milder concentration while still benefiting from effective hair growth stimulation.\n\nComposition of Minoxidil Topical Solution USP 2%\nActive Ingredient\nMinoxidil USP 2% w/v\n\nMinoxidil is a vasodilator that improves blood flow to hair follicles and helps extend the hair growth cycle.\n\nOther Ingredients\n\nDepending on the manufacturer, the formulation may also contain:\n\nPurified Water\nEthanol\nPropylene Glycol\nStabilizing agents\nPreservatives\n\nThese ingredients help ensure proper absorption and effectiveness of the solution.\n\nHow Does Minoxidil Topical Solution USP 2% Work?\n\nMinoxidil works by revitalizing shrinking hair follicles and prolonging the growth phase of the hair cycle.\n\nHair Growth Cycle Overview\n\nHair grows in three main stages:\n\n1. Anagen Phase (Growth Phase)\n\nThe active growth stage where hair follicles produce new hair strands.\n\n2. Catagen Phase (Transition Phase)\n\nA brief period where hair growth slows.\n\n3. Telogen Phase (Resting Phase)\n\nHair eventually sheds and makes way for new growth.\n\nIn people experiencing pattern hair loss, the anagen phase becomes shorter, and hair follicles gradually shrink.\n\nMechanism of Action of Minoxidil\n\nMinoxidil Topical Solution USP 2% works by:\n\nIncreasing Blood Circulation\n\nMinoxidil improves blood flow around hair follicles, ensuring better delivery of oxygen and nutrients.\n\nStimulating Dormant Hair Follicles\n\nIt helps reactivate weakened follicles that have stopped producing healthy hair.\n\nExtending the Growth Phase\n\nMinoxidil prolongs the anagen phase, allowing hair to grow thicker and longer.\n\nEnhancing Follicular Function\n\nHair follicles become healthier and more productive over time.\n\nIncreasing Hair Density\n\nRegular application can improve scalp coverage and hair volume.\n\nUses of Minoxidil Topical Solution USP 2%\n1. Treatment of Androgenetic Alopecia\n\nThe primary use of Minoxidil Topical Solution USP 2% is managing hereditary hair loss in both men and women.\n\nBenefits include:\nReduced hair thinning\nImproved hair density\nEnhanced scalp coverage\nSlowed progression of baldness\n2. Female Pattern Hair Loss\n\nMinoxidil 2% is commonly recommended for women experiencing:\n\nDiffuse hair thinning\nWidening hair part\nReduced hair volume\n\nMany dermatologists consider 2% Minoxidil a first-line treatment option for female hair loss.\n\n3. Early Hair Loss Management\n\nIndividuals noticing initial signs of hair thinning may benefit from early treatment to preserve existing hair.\n\n4. Hair Follicle Revitalization\n\nMinoxidil helps improve the condition of miniaturized follicles, encouraging healthier growth patterns.\n\n5. Hair Density Enhancement\n\nRegular use may result in fuller, thicker-looking hair over time.\n\nKey Benefits of Minoxidil Topical Solution USP 2%\nClinically Proven Hair Regrowth\n\nMinoxidil is one of the most extensively studied and scientifically validated hair growth treatments available today.\n\nNon-Invasive Treatment\n\nUnlike hair transplantation procedures, Minoxidil provides a non-surgical approach to hair restoration.\n\nImproved Hair Thickness\n\nMany users experience:\n\nThicker hair strands\nIncreased hair volume\nBetter scalp coverage\nSlows Progressive Hair Loss\n\nMinoxidil helps slow the natural progression of androgenetic alopecia.\n\nEasy to Apply\n\nThe topical solution can be applied directly to affected scalp areas using a dropper or applicator.\n\nSuitable for Long-Term Use\n\nWith proper medical guidance, Minoxidil can be safely used as part of a long-term hair care regimen.\n\nSupports Hair Follicle Health\n\nImproved blood circulation contributes to healthier follicular activity and stronger hair growth.\n\nBoosts Confidence and Appearance\n\nSuccessful hair regrowth can positively impact:\n\nSelf-esteem\nPersonal appearance\nSocial confidence\nPsychological well-being\nWho Can Use Minoxidil Topical Solution USP 2%?\n\nMinoxidil 2% may be suitable for:\n\nAdult men experiencing early-stage hair loss\nWomen with diffuse hair thinning\nIndividuals with hereditary hair loss\nPatients seeking non-surgical hair restoration options\nPeople looking to improve hair density\n\nA healthcare professional or dermatologist should determine whether this treatment is appropriate for your specific condition.\n\nHow to Apply Minoxidil Topical Solution USP 2%\n\nFor optimal results:\n\nStep 1\n\nEnsure the scalp is clean and completely dry.\n\nStep 2\n\nApply the recommended amount directly to the affected scalp area.\n\nStep 3\n\nGently spread the solution using fingertips if instructed.\n\nStep 4\n\nAllow the solution to dry naturally.\n\nStep 5\n\nWash hands thoroughly after application.\n\nStep 6\n\nUse consistently as directed by your healthcare provider.\n\nRegular application is essential for achieving the best outcomes.\n\nWhen Can Results Be Expected?\n\nHair regrowth is a gradual process.\n\nTypical Timeline\nFirst 1–2 Months\n\nSome users may notice temporary shedding as older hairs are replaced.\n\n3–4 Months\n\nInitial improvements in hair growth may become visible.\n\n4–6 Months\n\nHair density and scalp coverage may continue to improve.\n\n6–12 Months\n\nMaximum benefits are often observed with consistent long-term use.\n\nResults vary from person to person depending on age, genetics, and the severity of hair loss.\n\nWhy Choose Minoxidil Topical Solution USP 2%?\nTrusted Worldwide\n\nMinoxidil remains one of the most recommended hair regrowth treatments globally.\n\nProven Effectiveness\n\nNumerous clinical studies support its ability to promote hair growth and reduce hair loss.\n\nEasy Integration into Daily Routine\n\nApplication requires minimal time and effort.\n\nCost-Effective Hair Loss Solution\n\nCompared to surgical hair restoration procedures, Minoxidil offers an affordable alternative.\n\nSuitable for Men and Women\n\nThe 2% formulation is particularly popular among female users while also benefiting many men with mild to moderate hair loss.\n\nPossible Side Effects of Minoxidil Topical Solution USP 2%\n\nLike any medication, Minoxidil may cause side effects in some individuals.\n\nCommon Side Effects\nScalp Irritation\n\nSome users may experience:\n\nRedness\nItching\nDryness\nMild burning sensation\nFlaking or Scaling\n\nThe scalp may become slightly dry during treatment.\n\nTemporary Hair Shedding\n\nAn increase in hair shedding may occur during the initial weeks of treatment.\n\nThis is often a normal sign that older hairs are being replaced by new growth.\n\nLess Common Side Effects\nHeadache\n\nA small percentage of users may experience mild headaches.\n\nDizziness\n\nRarely, some individuals may feel lightheaded.\n\nUnwanted Hair Growth\n\nHair growth may occur in unintended areas if the solution comes into contact with other parts of the body.\n\nSerious Side Effects Requiring Medical Attention\n\nSeek immediate medical assistance if you experience:\n\nChest pain\nRapid heartbeat\nSevere dizziness\nSwelling of hands or feet\nDifficulty breathing\nSevere allergic reactions\n\nAlthough uncommon, these reactions require prompt evaluation.\n\nPrecautions and Warnings\nFor External Use Only\n\nMinoxidil Topical Solution USP 2% should only be applied to the scalp.\n\nAvoid Contact with Eyes\n\nIf accidental contact occurs, rinse thoroughly with water.\n\nDo Not Apply to Damaged Skin\n\nAvoid use on irritated, infected, or injured scalp areas.\n\nPregnancy and Breastfeeding\n\nConsult a healthcare provider before use during pregnancy or breastfeeding.\n\nKeep Away from Children\n\nStore safely and securely out of reach of children.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool, dry place.\nKeep away from direct sunlight.\nClose the container tightly after use.\nProtect from excessive heat and moisture.\nFrequently Asked Questions (FAQs)\nWhat is Minoxidil Topical Solution USP 2% used for?\n\nIt is used to treat hair loss and promote hair regrowth in individuals with androgenetic alopecia and hair thinning.\n\nIs Minoxidil 2% effective for women?\n\nYes. Minoxidil 2% is commonly recommended for female pattern hair loss.\n\nHow long should I use Minoxidil?\n\nHair growth maintenance generally requires continued use as directed by a healthcare professional.\n\nCan Minoxidil cure baldness permanently?\n\nNo. It helps manage hair loss and stimulate regrowth but does not permanently cure hereditary baldness.\n\nCan I use hair products while using Minoxidil?\n\nMost hair care products can be used, but it is advisable to apply them after the solution has completely dried.\n\nConclusion\n\nMinoxidil Topical Solution USP 2% is a trusted, clinically proven, and widely recommended treatment for hair loss and hair thinning. By improving blood circulation to hair follicles, extending the hair growth cycle, and stimulating dormant follicles, it helps promote healthier, thicker, and fuller hair growth over time.", "price": 395.0, "discountamount": 119.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2451, "imageuri": "https://productimages.withfloats.com/actual/6a2937c6210ffc3626055f86.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a2937c6210ffc3626055f86.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-10T10:09:08.796Z", "updatedon": "2026-06-10T10:09:08.796Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//minoxidil-topical-solution-usp-2-/2451", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MINOXIHAIR 2%", "category": "DERMATALOGY", "tags": [ "minoxidil topical solution usp 2%", "minoxidil topical solution usp 2 %", "minoxidil topical solution usp 2% w/v" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "69e9f8f5051af90911258c1b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "nebivolol 5mg cilnidipine 10mg", "description": "Nebivolol 5mg + Cilnidipine 10mg Tablets—Complete Guide\nA fixed-dose combination antihypertensive for effective blood pressure control. Understand how it works, who it's for, dosage, and safety before you buy.\n\nDrug Class\nBeta-blocker + Calcium Channel Blocker\nStrength\nNebivolol 5mg / Cilnidipine 10mg\nRoute\nOral (tablet)\nSchedule\nRx Only\nWhat is this combination?\nUnderstanding nebivolol 5mg + cilnidipine 10mg\nNebivolol 5mg + cilnidipine 10mg is a fixed-dose combination tablet prescribed for the management of hypertension (high blood pressure) in adults. It pairs two complementary mechanisms into one convenient pill, making it a popular choice when single-drug therapy proves insufficient for adequate blood pressure control.\n\nThis combination is widely preferred by cardiologists when patients need better BP reduction with fewer pills, improved tolerability, and protection of vital organs such as the heart and kidneys. If your doctor has prescribed this tablet, you're likely being treated for stage 1 or stage 2 hypertension, with or without associated cardiovascular risk factors.\n\nThis is not an over-the-counter product. Always use nebivolol + cilnidipine tablets only under the supervision of a licensed physician. Self-medication or dose changes without medical advice can be dangerous.\nHow it works\nMechanism of action — dual-pathway blood pressure control\nThe effectiveness of this combination lies in how its two active ingredients target blood pressure through different pathways simultaneously:\n\nNebivolol 5mg\nA third-generation cardioselective beta-1 blocker. It slows the heart rate, reduces the force of cardiac contraction, and lowers cardiac output. Uniquely, nebivolol also releases nitric oxide, causing blood vessel relaxation — a property not seen in older beta-blockers. This makes it better tolerated and less likely to cause sexual dysfunction or cold extremities.\nCilnidipine 10mg\nAn N/L-type calcium channel blocker. Unlike conventional CCBs (e.g., amlodipine), cilnidipine blocks both L-type and N-type calcium channels. N-type blockade in the sympathetic nervous system reduces norepinephrine release, leading to smoother, more sustained BP reduction with significantly less ankle swelling — a common complaint with older CCBs.\nTogether, these agents provide additive antihypertensive effect while offsetting each other's side effects. Nebivolol reduces tachycardia that CCBs can sometimes cause, while cilnidipine's vasodilatory effect complements nebivolol's cardiac output reduction.\n\nIndications\nWho is Nebivolol 5 mg and Cilnidipine 10 mg prescribed for?\nThis combination is indicated for adults with hypertension who are not adequately controlled on monotherapy. It is especially suited for patients who have:\n\nCondition:\tWhy this combination is preferred\nHypertension with high heart rate\tNebivolol slows heart rate while cilnidipine controls peripheral resistance\nHypertension with diabetes\tMetabolically neutral; does not worsen glucose tolerance or lipid profile\nHypertension with CKD / proteinuria:\tCilnidipine's N-type blockade reduces glomerular pressure and protein leakage\nHypertension with coronary artery disease\tNebivolol provides cardioprotection and anti-anginal effect\nAmlodipine-related ankle edema\tSwitching to cilnidipine substantially reduces pedal edema due to N-type blockade\nUncontrolled BP on single antihypertensive\tCombination adds complementary mechanisms without increasing pill burden\n\nosage & Administration\nHow to take nebivolol 5 mg + cilnidipine 10mg\nThe standard recommended dose is one tablet once daily, preferably at the same time each day — most commonly in the morning with or without food. Your physician may adjust the dose based on your blood pressure response and individual tolerability.\n\nDo not crush, chew, or split the tablet unless your doctor advises. If you miss a dose, take it as soon as you remember, but skip it if it is almost time for the next dose. Never double up on doses. Swallowing the tablet whole with water is the preferred method of administration.\n\nDo not stop taking this medication abruptly. Sudden discontinuation of nebivolol (a beta-blocker) can trigger rebound hypertension or even angina in patients with underlying coronary disease. Always taper under medical guidance.\n\nCommon and serious side effects to know\nLike all medicines, nebivolol + cilnidipine can cause side effects, though not everyone experiences them. Knowing what to watch for helps you respond promptly.\n\nSide effect\tFrequency\tWhat to do\nHeadache, dizziness\tCommon (early phase)\tUsually resolves in 1–2 weeks; avoid sudden posture changes\nFatigue, tiredness\tCommon\tMonitor; often improves after dose adjustment\nAnkle swelling (pedal edema)\tLess common than with amlodipine\tReport if worsening; may require dose review\nBradycardia (slow heart rate)\tUncommon\tSeek medical advice if heart rate <50 bpm\nNausea, stomach upset\tUncommon\tTake after meals to minimise\nBronchospasm\tRare\tStop immediately; seek emergency care if breathlessness\nSevere hypotension\tRare\tEmergency — seek immediate medical attention.\n\nWhen should this combination not be used?\nImportant safety information\nThis tablet is contraindicated in: cardiogenic shock, decompensated heart failure, severe bradycardia (<60 bpm), sick sinus syndrome, second- or third-degree AV block (without pacemaker), severe hepatic impairment, known hypersensitivity to nebivolol or cilnidipine, pregnancy, and breastfeeding.\n\nUse with caution in patients with asthma or COPD (nebivolol has some beta-2 activity at higher doses), peripheral vascular disease, diabetes mellitus (may mask hypoglycemic symptoms), and in elderly patients prone to falls due to postural hypotension.\n\nAlways inform your doctor of all medications you are currently taking. Clinically significant interactions exist with other antihypertensives, NSAIDs, digoxin, antidiabetic agents, and CYP2D6 inhibitors (e.g., fluoxetine, paroxetine), which can raise nebivolol plasma levels.\n\n\n\n\n", "price": 305.0, "discountamount": 91.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2389, "imageuri": "https://productimages.withfloats.com/actual/69e9f8f745652456a0f3a497.png", "tileimageuri": "https://productimages.withfloats.com/tile/69e9f8f745652456a0f3a497.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-04-23T10:48:21.085Z", "updatedon": "2026-04-29T05:46:26.285Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nebivolol-5mg-cilnidipine-10mg/2389", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NEBIVALVE CILNL 5/10", "category": "CARDIOLOGYRANGE", "tags": [ "nebivolol 5mg cilnidipine 10mg", "What is nebivolol 5mg and cilnidipine 10 mg used for?", "nebivolol cilnidipine", "nebivolol cilnidipine tab", "nebivolol cilnidipine uses", "nebivolol 5mg cilnidipine 10mg price", "nebivolol 5mg cilnidipine 10mg price in india", "nebivolol cilnidipine", "nebivolol 5mg cilnidipine 10mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "699990a8814d89cb6a29a9c8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ferric carboxymaltose injection", "description": "RUDIX FCM IV is a sterile intravenous iron formulation containing Ferric carboxymaltose, designed for the rapid and effective treatment of iron deficiency and iron deficiency anemia (IDA). It is specifically developed for patients who require fast iron replenishment, cannot tolerate oral iron supplements, or have conditions where oral iron therapy is ineffective.\n\nIron deficiency remains one of the most common nutritional deficiencies worldwide, affecting women, children, patients with chronic diseases, and individuals recovering from surgery. RUDIX FCM IV provides a modern, safe, and convenient approach to restoring iron stores efficiently under medical supervision.\n\nProduct Overview\n\nProduct Name: RUDIX FCM IV\n\nGeneric Name: Ferric Carboxymaltose Injection\n\nDosage Form: Intravenous injection / infusion\n\nRoute of Administration: IV use only\n\nIndication: Treatment of iron deficiency and iron deficiency anemia\n\nRUDIX FCM IV is formulated using advanced iron-carbohydrate complex technology that allows controlled and gradual release of iron into the bloodstream. This reduces the risk of free iron toxicity while ensuring effective replenishment of hemoglobin levels and iron stores.\n\nWhat is Ferric Carboxymaltose?\n\nFerric carboxymaltose is a next-generation intravenous iron complex. Unlike traditional iron salts, it allows the administration of larger single doses in a shorter duration, reducing the need for multiple hospital visits. The iron core is tightly bound within a carbohydrate shell, enabling controlled release and minimizing adverse reactions compared to older IV iron formulations.\n\nOnce administered, iron from ferric carboxymaltose is taken up by the body's iron-binding proteins and transported to the bone marrow, where it supports red blood cell production and improves hemoglobin levels.\n\nUses of RUDIX FCM IV\n\nRUDIX FCM IV is indicated in the following medical conditions:\n\n1. Iron Deficiency Anemia (IDA)\n\nUsed when oral iron therapy is ineffective, poorly tolerated, or when rapid correction of anemia is required.\n\n2. Chronic Kidney Disease (CKD)\n\nPatients with CKD often experience anemia due to reduced erythropoietin production and iron deficiency. IV iron helps restore iron levels efficiently.\n\n3. Postpartum Anemia\n\nWomen who experience significant blood loss during childbirth may require quick iron restoration.\n\n4. Heavy Menstrual Bleeding\n\nFor women with chronic blood loss leading to iron deficiency.\n\n5. Gastrointestinal Disorders\n\nConditions such as inflammatory bowel disease (IBD), celiac disease, or gastric surgery can impair iron absorption, making IV iron therapy necessary.\n\n6. Pre- and Post-Surgical Patients\n\nPatients undergoing major surgeries may require rapid iron replenishment to improve recovery.\n\nKey Benefits of RUDIX FCM IV\n✔ Rapid Iron Replenishment\n\nAllows administration of high doses in a single sitting, helping patients recover faster compared to oral supplements.\n\n✔ Improved Patient Compliance\n\nFewer hospital visits are required due to the ability to deliver larger doses in one infusion.\n\n✔ Better Tolerability\n\nLower incidence of gastrointestinal side effects compared to oral iron therapy.\n\n✔ Controlled Iron Release\n\nThe stable iron-carbohydrate complex reduces the risk of free iron reactions.\n\n✔ Suitable for Multiple Patient Groups\n\nSafe for use in adults with various underlying medical conditions under medical supervision.\n\n✔ Clinically Proven Effectiveness\n\nHelps improve hemoglobin levels, replenish iron stores, and reduce fatigue and weakness associated with anemia.\n\nDosage and Administration\n\nRUDIX FCM IV should be administered only by qualified healthcare professionals in a clinical setting. The dosage depends on:\n\nPatient’s body weight\n\nHemoglobin level\n\nSeverity of iron deficiency\n\nUnderlying medical condition\n\nIt may be given as a slow intravenous injection or diluted in saline for infusion. Monitoring during and after administration is recommended to ensure patient safety.\n\nPossible Side Effects\n\nLike all medications, RUDIX FCM IV may cause side effects, although not everyone experiences them.\n\nCommon Side Effects:\n\nHeadache\n\nNausea\n\nDizziness\n\nInjection site reactions\n\nFlushing\n\nLess Common but Serious Reactions:\n\nHypersensitivity reactions\n\nHypotension (low blood pressure)\n\nAllergic reactions\n\nShortness of breath\n\nPatients should be monitored during infusion. Immediate medical attention is required if signs of severe allergic reactions occur.\n\nPrecautions and Warnings\n\nShould not be used in patients with known hypersensitivity to ferric carboxymaltose.\n\nNot recommended in patients with iron overload disorders such as hemochromatosis.\n\nUse cautiously in patients with liver dysfunction.\n\nPregnancy and lactation use should be evaluated by a healthcare provider.\n\nMust be administered in facilities equipped to manage anaphylactic reactions.\n\nStorage Instructions\n\nStore at controlled room temperature.\n\nProtect from light.\n\nDo not freeze.\n\nKeep out of reach of children.\n\nWhy Choose RUDIX FCM IV?\nRUDIX FCM IV stands out due to its high-quality formulation, safety profile, and effectiveness in treating iron deficiency anemia. It offers healthcare providers a reliable option for rapid correction of iron deficiency while minimizing patient inconvenience.\n\nIts ability to deliver higher doses in fewer sessions makes it a preferred choice in hospitals, nephrology clinics, gynecology practices, and surgical recovery units.\nConclusion\nIron deficiency anemia can significantly impact quality of life, causing fatigue, weakness, reduced immunity, and impaired cognitive function. Timely correction is essential to restore overall health and vitality.", "price": 2050.0, "discountamount": 615.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2310, "imageuri": "https://productimages.withfloats.com/actual/699990ae4601efddb00d005a.png", "tileimageuri": "https://productimages.withfloats.com/tile/699990ae4601efddb00d005a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-21T11:02:00.008Z", "updatedon": "2026-05-27T10:36:01.116Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ferric-carboxymaltose-injection/2310", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RUDIX FCM IV", "category": "GYANECOLOGYRANGE", "tags": [ "ferric carboxymaltose injection 1000mg IV for anemia", "ferric carboxymaltose IV iron therapy dosage guide", "ferric carboxymaltose injection for iron deficiency anemia", "buy ferric carboxymaltose injection online", "ferric carboxymaltose IV injection price per vial", "ferric carboxymaltose injection 50 mg price", "ferric carboxymaltose injection price", "ferric carboxymaltose injection uses in hindi", "ferric carboxymaltose injection uses in hindi", "what is ferric carboxymaltose injection", "what is ferric carboxymaltose injection used for", "Ferric carboxymaltose injection" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6943af86161ad9de85f42b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "imatinib 400mg", "description": "IMATIFLOW 400, containing Imatinib IP 400mg, represents a breakthrough in targeted cancer therapy, offering patients a precise weapon against specific malignancies. This oral medication belongs to the class of tyrosine kinase inhibitors, revolutionizing treatment for conditions once deemed challenging to manage. By blocking abnormal proteins that fuel cancer cell growth, IMATIFLOW 400 helps restore normal cellular function and improves quality of life for many users.​\n\nProduct Overview\nIMATIFLOW 400 is a branded formulation of Imatinib mesylate 400mg, produced to high pharmaceutical standards for consistent efficacy and bioavailability. Each tablet delivers the active ingredient in a film-coated form, designed for once-daily administration with food to enhance absorption and minimize gastrointestinal upset. Developed for adult patients, it targets cancers driven by dysregulated tyrosine kinases like BCR-ABL, c-KIT, and PDGFR, making it a cornerstone in modern oncology protocols.​\n\nThe medication's mechanism hinges on competitive inhibition at the ATP-binding site of these kinases, halting downstream signaling pathways that promote uncontrolled proliferation, survival, and metastasis of malignant cells. Unlike traditional chemotherapy, which broadly attacks dividing cells, IMATIFLOW 400 spares most healthy tissues, leading to a more favorable safety profile. Clinical data from pivotal trials underscore its role as first-line therapy, with high response rates observed within months of initiation.​\n\nPrimary Uses\nIMATIFLOW 400 excels in treating chronic myeloid leukemia (CML), particularly in the chronic phase where it induces deep molecular responses in over 80% of patients. It suppresses the Philadelphia chromosome-positive cells hallmark of CML by inhibiting the BCR-ABL fusion protein, dramatically extending progression-free survival. For newly diagnosed patients, standard dosing starts at 400mg daily, often achieving complete cytogenetic remission.​\n\nIn gastrointestinal stromal tumors (GIST), IMATIFLOW 400 targets KIT or PDGFRA mutations, shrinking unresectable tumors and delaying progression in advanced cases. The recommended dose remains 400mg once daily, with potential escalation to 600-800mg for resistant strains, as per oncology guidelines. It also finds application in dermatofibrosarcoma protuberans (DFSP), aggressive systemic mastocytosis, and certain myelodysplastic syndromes, broadening its utility in precision medicine.​\n\nHealthcare providers monitor response via PCR for BCR-ABL transcripts in CML or imaging for GIST, adjusting therapy based on milestones like major molecular response. Patients with Ph+ acute lymphoblastic leukemia (ALL) may receive it adjunctively, enhancing outcomes when combined with chemotherapy. Overall, IMATIFLOW 400 transforms these diseases from fatal to chronically manageable.​\n\nKey Benefits\nOne standout benefit of IMATIFLOW 400 is its oral convenience, eliminating the need for frequent hospital visits associated with infusions. Response rates exceed 90% in early CML, with many patients achieving treatment-free remission after sustained deep responses, a paradigm shift from interferon-era therapies.​\n\nTumor control in GIST prevents life-threatening complications like bowel obstruction, improving survival from months to years. Its specificity reduces severe toxicities, allowing patients to maintain daily activities, work, and social engagements with minimal disruption. Long-term studies report 10-year survival rates above 80% in CML, underscoring durable efficacy.​\n\nAdditional advantages include cost-effectiveness over biologics and compatibility with supportive care like hydroxyurea for cytoreduction. Fluid retention, while common, responds well to diuretics, preserving cardiac function. For Indian patients, accessible pricing via brands like IMATIFLOW 400 supports equitable care in resource-limited settings.​\n\nPotential Side Effects\nWhile generally well-tolerated, IMATIFLOW 400 can cause edema (swelling in legs or face) in up to 70% of users, managed by dose reduction or supportive measures. Gastrointestinal issues like nausea, vomiting, and diarrhea affect 40-50%, often resolving with antiemetics and dietary adjustments.​\n\nMusculoskeletal pain, cramps, and fatigue occur frequently, alongside rash and abdominal discomfort. Hematologic effects include neutropenia or thrombocytopenia, necessitating regular blood counts. Rare but serious risks involve liver enzyme elevation, heart failure, or hemorrhage; prompt reporting of symptoms like shortness of breath or yellowing skin is crucial.​\n\nAvoid grapefruit juice, as it elevates drug levels, and inform doctors of concurrent medications like CYP3A4 inhibitors. Pregnancy category D status advises contraception, with monitoring for growth retardation in exposed fetuses. Dizziness may impair driving, so caution is essential during initial weeks.​\n\nDosage and Administration Guidelines\nSwallow IMATIFLOW 400 whole with a meal and full glass of water to optimize pharmacokinetics and reduce esophageal irritation. The standard adult dose for CML chronic phase is 400mg daily; for accelerated phase or blast crisis, 600mg. GIST dosing mirrors 400mg, titrated based on tolerance and response.​\n\nRenal or hepatic impairment requires dose adjustments—reduce to 300-400mg in moderate cases. Do not crush or chew tablets. Missed doses should be taken promptly unless near the next, avoiding doubles. Long-term use demands quarterly monitoring of CBC, liver function, and ECG.​\n\nPrecautions and Interactions\nPatients with a cardiac history need baseline echocardiograms, as QT prolongation or effusion risks exist. Drug interactions abound: St. John's wort induces metabolism, reducing efficacy; ketoconazole boosts levels. Vaccines, especially live ones, are contraindicated during therapy.​\n\nRegular dermatologic checks mitigate skin cancer risk from prolonged use. Hydration combats fluid retention, and low-salt diets aid management. Steris Healthcare emphasizes patient education via counseling on adherence for optimal outcomes.​\n\nConclusion\nIMATIFLOW 400 (Imatinib IP 400mg) stands as a testament to targeted therapy's power, offering robust control over CML, GIST, and related cancers with a balance of efficacy and manageability. Its benefits in prolonging life and enhancing daily functioning far outweigh transient side effects for most when monitored diligently. Consult oncologists for personalized plans, ensuring this innovative treatment maximizes hope and health in the fight against cancer.", "price": 1827.0, "discountamount": 540.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2249, "imageuri": "https://productimages.withfloats.com/actual/6943b026ca1b0dcfc6c37820.png", "tileimageuri": "https://productimages.withfloats.com/tile/6943b026ca1b0dcfc6c37820.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-18T07:38:46.766Z", "updatedon": "2026-04-15T10:27:12.329Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//imatinib-400mg/2249", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMATIFLOW 400", "category": "NEPHROLOGYRANGE", "tags": [ "Imatinib IP 400mg", "offering robust control over CML.", "related cancers with a balance of efficacy and manageability.", "innovative treatment maximizes hope and health in the fight against cancer.", "cancer therapy.", "fuel cancer cell growth.", "chemotherapy.", "imatinib 400mg.", "imatinib 400mg tablet.", "tab. imatinib 400mg.", "imatinib 400mg price.", "imatinib 400mg tab", "imatinib 400mg side effects.", "imatinib 400 mg tablet", "imatinib 400 mg medicine", "imatinib tablets 400 mg uses", "imatinib 400 mg dosage", "imatinib 400 mg price in india", "imatinib 400 mg brand name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }